Alembic Pharmaceuticals is currently trading at Rs. 741.10, up by 30.15 points or 4.24% from its previous closing of Rs. 710.95 on the BSE.
The scrip opened at Rs. 717.10 and has touched a high and low of Rs. 744.40 and Rs. 717.10 respectively. So far 17687 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 791.70 on 15-Jul-2015 and a 52 week low of Rs. 332.00 on 01-Aug-2014.
Last one week high and low of the scrip stood at Rs. 777.00 and Rs. 661.00 respectively. The current market cap of the company is Rs. 13850.26 crore.
The promoters holding in the company stood at 74.13% while Institutions and Non-Institutions held 12.28% and 13.59% respectively.
Alembic Pharmaceuticals has reported 24.11% rise in its net profit at Rs 76.30 crore for the quarter ended June 30, 2015 as compared to Rs 61.48 crore for the same quarter in the previous year. The company’s total income has increased by 19.28% to Rs 574.89 crore for the quarter under review from Rs 481.98 crore for the corresponding quarter of the previous year.
On the consolidated basis, the company has reported 8.06% rise in its net profit after taxes, minority interest and share of profit /(Loss) of associates of Rs 69.88 crore for the quarter ended June 30, 2015 as compared to Rs 64.67 crore for the same quarter in the previous year. Total income of the company has increased by 17.98% at Rs 583.37 crore for quarter under review as compared to Rs 494.46 crore for the quarter ended June 30, 2014.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |